Paxman KTP to create new device to prevent chemotherapy side-effect CIPN (IMAGE)

University of Huddersfield

Paxman KTP to create new device to prevent chemotherapy side-effect CIPN

Caption

A two-year ‘Knowledge Transfer Partnership’ between the University and Paxman will design and develop a medical cooling system for the prevention of Chemotherapy-induced peripheral neuropathy (CIPN), a common, dose-limiting side-effect experienced by 30%-40% of patients receiving chemotherapy for cancer of which no effective prevention and treatment strategies currently exist

Credit

Paxman and the University of Huddersfield

Usage Restrictions

For republishing this news content only

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.